Best Startup
At Best Startup US we track over 1,000,000 US startups and over 3 million people who hold key positions in these companies. We use this directory of startups to highlight top employees, founders and board members we think deserve more appreciation than they are currently getting.
This list showcases the top United States based Founder operating in the Medical space. If you think a Founder is missing from this list, feel free to contact our editor on editor@beststartup.us.
The individuals on this list have been included because of exceptional performance in one of the following categories:
- Innovation – Operating as a key part in an extremely innovative business or startup.
- Growth – Operating as a key figure in the growth and upscale of a market leading business or startup.
- Management – Showing exceptional management skills.
- Societal impact – Putting their business on the map for their positive societal or environmental impact.
Our Data – We source our data from OSINT (open source intelligence) and public directories such as Crunchbase, SemRush and many more. The data from these sources should be treated with a degree of caution and verified yourself.
Lin Jixun
Founder & CEO of ACON Laboratories
Lin Jixun has served as our director since 2008 and is the founder and chief executive officer of ACON Laboratories Inc., a worldwide leading manufacturer of high-quality rapid diagnostic test products. Mr. Lin founded ACON Laboratories Inc. in 1995 and serves on the company’s board of directors. He also serves on the board of directors for ACEA BioSciences Inc., a company providing innovative cell-based assay systems for basic life science research and drug discovery. Mr. Lin received his Ph.D. in microbiology and immunology from the Medical University of South Carolina and a Bachelor of Medicine from Zhejiang Medical University.
Follow Lin Jixun:
About ACON Laboratories: ACON Laboratories is a biotechnology firm that offers medical diagnostic and healthcare products.
_______
Adam Karp
Co-Founder & CEO of Lively
Prior to Lively, Adam was the Chief Marketing Officer of 1stdibs – the world’s premier destination for unique, luxury design. At 1stdibs, Adam was instrumental in increasing the company’s revenue almost 10x; recruited and led a team of 100 and had full P&L responsibility for 1stdibs’ B2B business. Before 1stdibs Adam worked in senior roles at leading brands such as FreshDirect, Barnes & Noble and Century 21 real estate. At Century 21 he was responsible for developing and launching Century 21’s first website which at the time became the most recognized real estate website in the country and currently generates almost 50 million visits a year. After Century 21, Adam spent almost a decade at Barnes & Noble in increasingly senior roles ultimately becoming VP of Direct Marketing for both the retail stores and online. At Barnes & Noble, Adam managed some of the largest digital marketing programs in the industry, overseeing a budget of $100M. Adam graduated from the The Wharton School at the University of Pennsylvania with a degree in Economics.
Follow Adam Karp:
About Lively: Lively’s mission is to democratize, simplify and de-stigmatize the adoption and use of technically advanced hearing aids.
Elad Kolet
Co-Founder & CTO of Lively
Elad is a technology leader with more than 15 years of experience in software engineering. Most recently Elad ran the North America Solutions Engineering team at Facebook where he managed a team of 32 full-stack engineers responsible for building Facebook’s advertising products. Prior to working at Facebook, Elad worked as an Engineering Lead at Microsoft, driving the development of Windows Azure. Before Microsoft, Elad was a Senior Software Engineer at RiT technologies LTD., where he designed and built network products used by large corporate clients including Goldman Sachs UK and Morgan Stanley UK. Elad was raised in Israel and spent four years as a software engineer in the Israeli Intelligence Corps’ Unit 8200, an incubator of tech talent whose alumni have gone on to found numerous technology companies. Elad earned his BS in Computer Science from the Academic College of Tel-Aviv, Yaffo.
Follow Elad Kolet:
About Lively: Lively’s mission is to democratize, simplify and de-stigmatize the adoption and use of technically advanced hearing aids.
David Rust
Co-Founder & Advisor of Lively
David is a seasoned operator who helped scale Lyft from 25 to 1,600 employees and an $11B+ valuation. He launched Lyft’s first markets across the US and translated these learnings into the company’s national expansion playbook. David then went on to build and lead Lyft’s internal strategy team, reporting to Lyft’s COO. This team was responsible for leading high-priority strategic initiatives, from Lyft’s partnership with General Motors to its first self-driving car implementations. Prior to Lyft, David led market expansion and local marketing for one of the early pioneers in the car sharing industry, Wheelz, which was acquired by RelayRides (not Turo). David graduated from Stanford University with a degree in Environmental Engineering and was named as a member of the Forbes 30 Under 30 class of 2017.
Follow David Rust:
About Lively: Lively’s mission is to democratize, simplify and de-stigmatize the adoption and use of technically advanced hearing aids.
Esther Dyson
Founder of Way to Wellville
Follow Esther Dyson:
About 23andMe, Commercial Spaceflight Federation, EDventure Holdings, GridPoint, HICCup, New York Angels, Way to Wellville, Wellgood: 10-year nonprofit project to show impact of investing in health (vs. renting it)
George Archos
Co-Founder, Chairman and CEO of Verano Holdings
George Archos is the founder & CEO of Verano Holdings. He is a logistics and operations guru. Building on his extensive experience in coordinating complex freight delivery operations, as well as designing and operating highly-successful restaurants, George entered the cannabis industry in 2014 when he founded Ataraxia Grow and Labs in Illinois and was the first to receive authorization to grow medical cannabis out of 21 recipients of the coveted medical licenses. George’s diligence, perseverance, and tireless work ethic have made him one of the cannabis industry’s most successful entrepreneurs. Leveraging his unparalleled devotion to quality and a unique results-oriented approach to the cannabis industry, George has overseen the development of some of cannabis’s most highly-coveted operations and brands. George’s restaurants across the Chicagoland area, including Wildberry Pancakes & Café, Westwood Tavern & Tap and the Scout Waterhouse & Kitchen, all bear the imprint of his relentless devotion to quality and unrivaled customer service, earning him multiple awards and recognition. George’s unique experience, his admirable drive, and his unrelenting commitment to quality, coupled with his capacity to establish, build, and effectively run multi-jurisdictional companies, are an asset to Verano Holdings.
Follow George Archos:
About Verano Holdings: Verano is a vertically integrated, multi-state cannabis operator.
Yury Yakubchyk
Founder of Elemy
Yury Yakubchyk is the Founder of Sprout Therapy. He is also the Chief Technology Officer at Life House, where he manages the technology, growth marketing, data analytics, and digital design teams. Yury is responsible for Life House’s unique digital strategy. Previously, Yury was a Chief Technology Officer at New York-based Wing (wingalpha.com, Wing Tel, and Wing Call on the Apple App Store), a modern millennial-tailored mobile virtual network operator selling custom cellular subscription plans and mobile devices on the Sprint network. The wing is venture-backed by several prominent venture capital firms and angel investors. Prior to Wing, Yury worked in the financial services industry. Yury is a self-taught programmer and digital product designer as well as a graduate of the Johns Hopkins University, where he was a Woodrow Wilson Fellow. Yury is originally from New York City.
Follow Yury Yakubchyk:
About Cold Start Ventures, Elemy, Life House, Wing Tel, Inc.: Elemy is a B2B2C platform helping provide access to in-home pediatric care for ongoing behavioral challenges, including autism.
Founder & CEO of Viome
Naveen Jain is an entrepreneur and philanthropist driven to solve the world’s biggest challenges through innovation. He is the founder of several successful companies including Moon Express, BlueDot, Viome, Intelius, TalentWise and InfoSpace. Moon Express is the only company to have permission from the US government to leave earth orbit and land on the moon. It’s developing technologies to harvest planetary resources on the moon for the benefit of humanity. BlueDot is focused on bringing most promising technological innovations from the national labs, NASA and elite universities and supercharging them with great entrepreneurs to create successful enterprises that tackle humanity’s grand challenges. Viome is focused on discovering predictive biomarkers to eradicate all diseases. Our initial goal is to provide personalized diet & nutrition based on deep analysis of microbiome, metabolome and meta genomics. Naveen Jain a trustee of the board and vision circle member at the X PRIZE Foundation where he is focused on finding entrepreneurial solutions to address the global challenges in health, education, women empowerment, agriculture, and energy. Naveen Jain is on the board of Singularity University, an interdisciplinary university with the mission to educate and inspire leaders to address humanity’s grand challenges through innovative technologies. Naveen Jain has been awarded many honors for his entrepreneurial successes and leadership skills including “Ernst & Young Entrepreneur of the Year”, “Albert Einstein Technology Medal” for pioneers in technology, “Humanitarian Innovation Award” at the United Nations, “Distinguished Global Thinker Award” by IILM, “Most inspiring Entrepreneur” by Andaaz TV, “Most admired Serial Entrepreneur” by Silicon India, “Top 20 Entrepreneurs” and “Lifetime Achievement Award” for the leadership in the technology industry and support of other entrepreneurs by Red Herring.
Follow Naveen Jain:
About Bellevue LifeSpring, BlueDot, Moon Express, TalentWise, Viome, World Innovation Inc: Viome is a provider of comprehensive health insights designed to help people track their gut microbiome health.
Yi Liu
Founder & CEO of iHealth Labs
Follow Yi Liu:
About iHealth Labs: iHealth offers cloud-based, personal healthcare products for individuals of all ages to take a more active role in managing their health.
Stephanie Tilenius
CEO, Founder of Vida Health
Stephanie is CEO & Founder of Vida Health.
Follow Stephanie Tilenius:
About Nextdoor, Vida Health: Vida Health is a virtual care platform that provides health coaching from experienced health care providers and medical institutions.
Raja Dhir
Co-Founder and Co-CEO of Seed Health
Raja Dhir is a life sciences entrepreneur and Co-Founder of Seed Health, a venture-backed microbiome company pioneering the application of bacteria for both human and planetary health. He leads Seed’s R&D, academic collaborations, technology development, clinical trial design, supply chain, and intellectual property strategy. Together with Dr. Jacques Ravel, he Co-Chairs Seed’s Scientific Advisory Board–an interdisciplinary group of scientists and doctors who lead research teams and teach at institutions including the teaching hospital of Harvard Medical School and the Trial Innovation Unit of Mass. General Hospital (MGH). Raja has designed clinical trials with leading academic institutions including the teaching hospital of Harvard Medical School and the Trial Innovation Unit of Mass. General Hospital (MGH). Raja has unique expertise translating scientific research for product development with a track record that includes patented inventions to stabilize sensitive compounds to improve alpha-diversity of the gut microbiome (derived from micro-algae) and most recently, the co-invention of microbial technologies to protect honeybee populations (Apis mellifera) from neonicotinoid pesticides and pathogen colonization. His work also includes biofermentation and scale-up for both facultative and strict anaerobic organisms. Raja has negotiated multiple joint-ventures, strategic partnerships, technology transfer and licensing agreements with publicly traded companies (NYSE, LSE) and academic institutions (Harvard Medical School, UCLA). To date, entities he has co-founded own the rights to 15+ patents and research emerging from $25MM+ of non-dilutive funding over 10+ years from the Bill and Melinda Gates Foundation and National Institute of Health (NIH). Raja serves on the Editorial Board for the scientific journal, Microbiome. He is a member of the Microbiome Think Tank at Mass. General Hospital (MGH) and sits on the Advisory Committee for the International Scientific Association of Probiotics and Prebiotics (ISAPP). Raja is also a Director and Co-Chair of the Scientific Advisory Board for Micropia, a $20MM microbial ecology / education platform and the world’s first museum dedicated to microbes.
Follow Raja Dhir:
About Seed Health: Seed Health is a microbial company that focuses on therapeutics, consumer health innovations, and environmental solutions.
Ara Katz
Co-Founder and Co-CEO of Seed Health
Ara Katz is the Co-Founder and Co-CEO of Seed Health, a microbial sciences company pioneering the application of bacteria to impact human and planetary health. She has worked at the intersection of technology, consumer, design, and media is now working to steward a new standard in probiotics and how science is communicated to change how we discern evidence from evangelism to make the most informed choices for our bodies, our health, and our world. Ara previously co-founded and served as CMO of mobile commerce marketplace, Spring (backed by LMVH, sold to ShopRunner), and was on the founding team of social commerce company, BeachMint (sold to Conde Nast), where she launched six direct-to-consumer, influencer subscription brands. She is an angel investor and advisor in companies such as mindbodygreen, Stadium Goods (recently sold to FarFetch), RXDefine, women’s healthcare startup, Mahmee, and new biomaterials company, C16. Ara has been a fellow at the MIT Media Lab’s Center for Future Storytelling and CCA’s Design MBA program, was named in Marie Claire’s “The New Guard: The 50 Most Influential Women in America”, listed on Business Insider’s “Silicon Alley Top 100” and “36 Rockstar Women in NYC Tech”, and Create + Cultivate’s 100 List for STEM.
Follow Ara Katz:
About Seed Health: Seed Health is a microbial company that focuses on therapeutics, consumer health innovations, and environmental solutions.
Mitchell Rales
Co-Founder of Danaher
Mitchell Rales is a co-founder of Danaher and has served on Danaher’s Board of Directors since 1983, serving as Chairman of the Executive Committee of Danaher since 1984. He was also President of Danaher from 1984 to 1990. In addition, for more than the past five years he has been a principal in private and public business entities in the manufacturing area. Mitchell is a member of the board of directors of Colfax Corporation, and is a brother of Steven Rales. The strategic vision and leadership of Mitchell and his brother, Steven Rales, helped create the Danaher Business System and have guided Danaher down a path of consistent, profitable growth that continues today. In addition, as a result of his substantial ownership stake in Danaher, he is well-positioned to understand, articulate and advocate for the rights and interests of Danaher’s shareholders.
Follow Mitchell Rales:
About Danaher: Danaher is a global science and technology innovator committed to helping their customers solve complex challenges and improve quality.
Steven Rales
Co-Founder of Danaher
Steven Rales is a co-founder of Danaher and has served on Danaher’s Board of Directors since 1983, serving as Danaher’s Chairman of the Board since 1984. He was also CEO of Danaher from 1984 to 1990. In addition, for more than the past five years he has been a principal in private business entities in the area film production. Steven is a brother of Mitchell Rales. The strategic vision and leadership of Steven and his brother, Mitchell Rales, helped create the Danaher Business System and have guided Danaher down a path of consistent, profitable growth that continues today. In addition, as a result of his substantial ownership stake in Danaher, he is well-positioned to understand, articulate and advocate for the rights and interests of Danaher’s shareholders.
Follow Steven Rales:
About Danaher: Danaher is a global science and technology innovator committed to helping their customers solve complex challenges and improve quality.
Jasen Trautwein
Chief Visionary Officer and Co-Founder of Pathway Partners Vet Holding
Jasen Trautwein, DVM, founded Pathway Partners Vet Holding LLC in 2012 and also serves as its Pathway Partners Vet Holding LLC. Mr. Trautwein is the Owner of Veterinary Medical Associates, Austin, TX. Mr. Trautwein is an Owner of Austin Vet Care since 2003. He has been Consulting Veterinarian and Board Member at Capital of Texas Zoo since 2003. He direct zoo staff in vaccination schedules and parasite control; Perform Annual USDA inspections and responsible for medical zoo population. He was Associate Veterinarian of Anderson Mill Animal Clinic, Austin, TX from 2000 to 2003. He was responsible for care of hospitalized patients; performing routine small animal surgeries and Diagnosis and treatment of outpatients. He is a Member of VMG-1. He was the President of Capital Area Veterinary Medical Association from 2006 to 2010. He serves as a Member of Veterinary Advisory Board at Trupanion, Inc. He is a Member of TVMA, AAHA, CAVMA, AVMA and VECCS. He is a Texas A&M Student Chapter IAAAM President in 1997. He holds Doctor of Veterinary Medicine from Texas A&M College of Veterinary Medicine, Texas A&M University in 2000. He holds Bachelor of Science in Zoology from The University of Texas in 1996.
Follow Jasen Trautwein:
About Pathway Partners Vet Holding, Veterinary Growth Partners: Pathway Vet Alliance is a veterinary hospital owner and operator.
Shawn McVey
Chief Culture Officer and Co-Founder of Pathway Partners Vet Holding
Shawn is an open, honest person who will push all the right buttons to get you to work together as a team and realize your full potential as a leader. He combines his background as a psychotherapist with 20 years of in-the-trenches experience building specialty and emergency practices to show you what “is” in your practice, along with what “could be.” He knows how to get you there—to a workplace that’s more team-oriented, flexible, happy, respectful, and productive. Shawn advises and trains veterinary practice teams approximately 50 times per year, and he would love to talk with you about how he can work magic in your practice.
Follow Shawn McVey:
About Pathway Partners Vet Holding, Veterinary Growth Partners: Pathway Vet Alliance is a veterinary hospital owner and operator.
Brian McCormack
CO-Founder of Cresco Labs
Follow Brian McCormack:
About Cresco Labs: Cresco Labs is a vertically-integrated multi-state cannabis operator inciting the progressive evolution of the medical cannabis industry.
Charlie Bachtell
Founder and CEO of Cresco Labs
Charles Bachtell serves as Co-Founder and Chief Executive Officer at Cresco Labs, LLC. He served as an Executive Vice President and General Counsel at Guaranteed Rate, Inc. Charles Bachtell served as the head of the legal and loss mitigation departments at Guaranteed Rate. He managed matters concerning legal, regulatory/legislative compliance, credit risk, corporate governance, and acquisitions, among others. Additionally, he is a board member of the Guaranteed Rate Foundation, the company’s nonprofit (501 c3) arm. Charles Bachtell worked with Guaranteed Rate. He obtained his Bachelor of Science degree in business administration with an emphasis in finance from the University of Arizona from 1996 to 2000 and his Juris Doctor from DePaul University College of Law.
Follow Charlie Bachtell:
About Cresco Labs: Cresco Labs is a vertically-integrated multi-state cannabis operator inciting the progressive evolution of the medical cannabis industry.
Joe Caltabiano
Co-Founder and President of Cresco Labs
Joseph “Joe” Caltabiano is a well-known and influential figure in the cannabis business, as well as the CEO of Choice Consolidation Corp., a special purpose acquisition company (“SPAC”) targeting an acquisition of one or more cannabis businesses or assets that can create a best-in-class cannabis multi-state operator (“MSO”). Prior to launching Choice, Caltabiano co-founded Cresco Labs, one of the most successful multi-state operators in the United States. Living and working in the Chicago metropolitan area, Caltabiano is a mentor who regularly advises both new and existing companies. His experience has covered a broad spectrum of disciplines, and he uses this diverse and extensive financial knowledge of retail, real estate, management, and the regulated cannabis sector to uncover new possibilities for investors. As a philanthropist and a childhood leukemia survivor, Caltabiano is also a significant contributor to organizations seeking a cure for cancer and supporting patients and their families.
Follow Joe Caltabiano:
About Cresco Labs: Cresco Labs is a vertically-integrated multi-state cannabis operator inciting the progressive evolution of the medical cannabis industry.
Sam Santhosh
Founder Chairman & Global CEO of MedGenome
Sam Santhosh is the Founder and CEO of MedGenome. He has been an entrepreneur, with over 20 years of experience in the software industry. Currently, he is at the helm of affairs as CEO and promoter of MedGenome Labs Pvt Ltd. Sam sits on the board of a number of companies, both in the US and India. In this role he advises, guides and mentors companies to help them grow and realize their true potential. Prior to this Sam was the CEO and Managing Director of California Software Limited (Calsoft) from 1992 – Feb 2012. He founded Calsoft in 1992 and under Sam’s vision, Calsoft rapidly grew from a niche player in the Silicon Valley to a global player with over 1200 employees and presence in 8 countries. Sam took Calsoft Public and the company is listed the in Indian Stock Exchanges. Sam oversaw the growth of Calsoft in all key areas – Finance, Strategy, Customer Acquisition, and inorganic growth through eight acquisitions including companies in the U.S, UK, Japan, and India. He has been constantly retooling himself and has attended various training programs in different U.S universities including MIT. In 2010, he completed the Executive Education program at the Singularity University in Sunnyvale, California. Sam has an engineering degree and an MBA (majoring in Management Information Systems) from India’s premier institute, IIM Calcutta.
Follow Sam Santhosh:
About Agrigenome, MedGenome: MedGenome develops a genomics-based diagnostics and research solution for healthcare providers to understand the genetic basis of diseases.
Brent Clements
Founder & CEO of Addiction Campuses of America
Brent is an accomplished entrepreneur, executive, and healthcare visionary. With over 20 years experience in senior leadership roles for multiple organizations in the healthcare and technology industries, Brent has a clear plan for what is required to build a successful company. Brent’s passion for helping those families in need inspired the founding of Addiction Campuses. Throughout his professional career Brent has developed expertise in creating strategy for the future, maximizing organizational efficiency, and building relationships with care givers, employees and community partners who drive change. Ultimately Brent believes “If they change the core belief system, the mindset changes and good behavior follows”. That is what Addiction Campuses is all about. He was recognized as one of Nashville Business Journal’s 40 Under 40 in 2011 and Healthcare Heroes nominee in 2010. Brent is married to his wife, Vicki, and they have two sons.
Follow Brent Clements:
About Addiction Campuses of America: Addiction Campuses of America owns, operates and manages behavioral healthcare campuses across the United States.
Dr. Jon Einarsson
Founder & Inventor of Lattis Surgical
Follow Dr. Jon Einarsson:
About Harvard Medical School, Lattis Surgical: The Lattis team developed a Contained Tissue Extraction (CTE) device, using bladeless technology.
Alexander Isakov
Founder & CEO of Lattis Surgical
Follow Alexander Isakov:
About Lattis Surgical: The Lattis team developed a Contained Tissue Extraction (CTE) device, using bladeless technology.
Jordan Smith
Founder & Board of Directors of Lattis Surgical
Follow Jordan Smith:
About Lattis Surgical: The Lattis team developed a Contained Tissue Extraction (CTE) device, using bladeless technology.
Brad Packer
Founder and CEO of Vitality Medical
Brad is the brains behind it all. Brad started Vitality Medical in 2000 shortly after completing his graduate degree from Medical College of Virginia. While employed as a registered nurse Brad recognized the need for online medical supplies and seized the opportunity to start Vitality Medical. Working weekend nights as a nurse and weekdays as entrepreneur Brad and his team of dedicated co-workers have created one of the foremost leading companies in the online medical supply market.
Follow Brad Packer:
About Vitality Medical: Vitality Medical provides quality home medical supplies and hospital equipment.
Christopher Morris
Founder & CEO of Daybreak Health
Christopher is an Internal Medicine and HIV specialist at NYU Langone Medical Center focused on digital health innovations as means to transform health care quality and access. He is most interested in using emerging telehealth technologies to transform the primary care experience.
Follow Christopher Morris:
About Daybreak Health, NYU Langone Health, NYU Langone Medical Center: Daybreak Health is a digital health platform that facilitates mobile care solutions.
Odero Otieno
Founder and Chief Technology Officer in Residence of Texas Medical Center
As a Founder and Chief Technology Officer in Residence at the Texas Medical Centre (TMC) Innovation in Houston, Odero works with other talented innovators from diverse backgrounds to quickly bring breakthrough products to market. Odero’s work involves collaborating with various key stakeholders from TMC member institutions ($25B in annual revenue), a global network of advisors and embedded corporate partners within the broader American healthcare ecosystem.
Follow Odero Otieno:
About DawaSwift, Entrepreneur First, HealthBank, Healthipy, Texas Medical Center: Texas Medical Center (TMC) is a life sciences medical complex focused on patient care, research, education, and prevention.
Stefano Migliorisi
Founder & CEO of swyMed Incorporated
Follow Stefano Migliorisi:
About swyMed Incorporated: swyMed’s solutions power truly mobile, real-time video telemedicine encounters at the lowest bandwidths.
Gregory Winter
Scientific Founders of Bicycle Therapeutics
Professor Sir Gregory Winter is a member of the Medical Research Council Laboratory of Molecular Biology (LMB) in Cambridge and most of his scientific career was based there. He was Head of Division of Protein and Nucleic Acid Chemistry, succeeding Cesar Milstein and has served as both Deputy and Acting Director of the LMB. He is a Fellow of the Royal Society, was knighted in 2004 for services to science and in 2012 was appointed by the Queen as Master of Trinity College, Cambridge. Sir Gregory is a graduate of University of Cambridge (1973), specialising in chemistry and biochemistry; for his PhD (1976) and postdoctoral work (1977-1981) he specialised in protein and nucleic acid sequencing respectively and with colleagues determined the genome sequence of influenza virus. From 1982 he pioneered the science of protein engineering, focusing first on enzymes (with A. Fersht) and then antibodies. He invented techniques to humanise rodent antibodies for use as therapeutics (1986–), working with H. Waldmann in the development of alemtuzumab/Campath-1H. Later, in competition with R. Lerner, he developed methods to make fully human antibodies (1989–) against human self-antigens using antibody libraries. His inventions are used in most of the antibody products on the market, including the humanised antibodies alemtuzumab/Campath-1H, trastuzumab/Herceptin, bevacizumab/Avastin, palivizumab/Synagis and the first human antibody (adalimumab/Humira) to be approved by the US FDA. Sir Gregory has acted as an entrepreneur to translate his scientific inventions to medicines. He was a founder of Cambridge Antibody Technology (CAT,1989) and Domantis (2000); these companies pioneered the use of antibody libraries to make fully human antibody therapeutics. CAT was floated on the London Stock Exchange in 1997 and was responsible for the co-development of the therapeutic antibodies adalimumab/Humira and belimumab/Benlysta. CAT was acquired by AstraZeneca in 2006. Domantis developed a range of product leads based on single antibody domains and was acquired by GSK in 2006 in a private sale. Sir Gregory has won several international scientific prizes, including the Prix Louis Jeantet de Medecine (Switzerland) in 1989; the King Faisal International Prize for Medicine (Molecular Immunology, Saudi Arabia) in 1995; the Biochemical Analysis Prize of the German Society for Clinical Chemistry in 1995; the Cancer Research Institute William B. Coley Award (US) in 1999; and the Royal Medal of the Royal Society in 2011. For his work with industry, he received the National Biotechnology Ventures Award (US) in 2004 and the BioIndustry Association Award (UK) in 2008. In March 2013 he was awarded the Gairdner Prize for the engineering of humanised monoclonal antibodies and their widespread use in medical therapy, particularly for treatment of cancer and immune disorders.
Follow Gregory Winter:
About Ahren Innovation Capital, Bicycle Therapeutics, MRC Laboratory of Molecular Biology, Trinity College, Dublin: Bicycle Therapeutics is developing a technology for the creation of new generation biotherapeutics.
Christian Heinis
Scientific Founders of Bicycle Therapeutics
Christian Heinis is Scientific Founders at Bicycle Therapeutics.
Follow Christian Heinis:
About Bicycle Therapeutics: Bicycle Therapeutics is developing a technology for the creation of new generation biotherapeutics.
Herb Yoo
Co-Founder, CTO of Senaptec
Herb has extensive experience in the innovation and delivery of sensory performance products and services. While working for Nike, he created sensory assessment and treatment tools resulting in over 25 patents and directed the sensory research program that led to collaboration and published work with research universities. He also provided sensory performance training directly to professional sports teams, college athletic programs, and special operations units in the US military. Herb also spent 8 years in the Nike Sport Research Lab, conducting performance product research and conceptualizing athlete performance evaluation services. He completed both undergraduate work and Masters degree at the University of Michigan in the College of Engineering where he studied human factors and biomechanics. During his graduate school years, he conducted research on the visual demand and impact of in-vehicle systems on driving performance at the University of Michigan Transportation Research Institute. Herb lives near Portland, Oregon with his wife Christine and two children.
Follow Herb Yoo:
About Senaptec: Senaptec is developing a portfolio of tools to assess and improve brain health and performance.
David Deacon
Co Founder, COO of Ria Health
Follow David Deacon:
About Ria Health: Ria Health’s evidence-based telehealth alcohol treatment program helps people drink less and live better.
Paul Chang
President, CEO/CSO and Lead Founder of ARase Therapeutics
Follow Paul Chang:
About ARase Therapeutics: Arase Therapeutics is a science-focused oncology company developing therapies that modulate cancer-relevant cell signaling pathways.
Bridget Osetinsky
Founder & CEO of Hyperfine
Bridget is the Founder and Chief Executive Officer of Hyperfine. She earned her Juris Doctor from Temple University James E. Beasley School of Law in 2011 and her Bachelor of Science in Physics from the University of Notre Dame in 2007.
Follow Bridget Osetinsky:
About Hyperfine: Advanced Analytics For Precision Medicine
Andrew Ninh
Co-Founder and CSO of Docbot
Follow Andrew Ninh:
About Docbot: Docbot is an AI technology company that offers AI-assisted image analysis solutions to revolutionize gastrointestinal care.
William Karnes
Co-Founder and Chief Medical Officer of Docbot
Follow William Karnes:
About Docbot, UC Irvine Health: Docbot is an AI technology company that offers AI-assisted image analysis solutions to revolutionize gastrointestinal care.
Branko Cerny
Founder of SquareOne
Branko Cerny joined Radical as Founder, CEO in 2017
Follow Branko Cerny:
About Radical, SquareOne, SquareOne Mail, Wasabi Ventures: SquareOne works with the biggest and most established personalities and content creators in gaming.
Jennifer Jacobs
Co-Founder COO of PerceptiMed
Follow Jennifer Jacobs:
About PerceptiMed: PerceptiMed develops an advanced pill identification system designed to eliminate human errors in medication dispensing in pharmacies.
Jennifer Jacob
Co-Founder of PerceptiMed
With a successful background in accounting, human resources and business engagement, Jenn oversees day-to-day operations of PerceptiMed while evangelizing the benefits of its VeriFill products. Prior to co-founding PerceptiMed, Jenn handled sales and marketing for Perseid Professional Services, a private consulting firm. She also provided executive financial services, strategic business management consulting and infrastructure creation for both start-up and established high tech companies. Previously Jenn served as the business development officer at Greater Bay Bank, which was a community bank subsidiary of Greater Bay Bancorp (acquired by Wells Fargo 2008). She is credited with closing more than $20 million in annual sales. Prior to that she was vice president and COO for Ulta.com, an on-line initiative for Ulta, Inc. She has also served in various controller positions at Interwise, Inc.; Metromedia Fiber Networks; and Associated Venture Networks. She has also served as an accountant for Arthur Anderson, LLC, and Price Waterhouse, LLC. Jennifer received a bachelor’s of science degree in accounting, cum laude, from the University of Maryland. She additionally holds a CPA and a certificate in mediation from The University of California at Berkeley.
Follow Jennifer Jacob:
About PerceptiMed: PerceptiMed develops an advanced pill identification system designed to eliminate human errors in medication dispensing in pharmacies.
Sahil Diwan
Co-Founder & CEO of SafKan Health
Follow Sahil Diwan:
About SafKan Health: Ear care for the 21st century.
Aadil Diwan
Co-Founder & CTO of SafKan Health
Follow Aadil Diwan:
About SafKan Health: Ear care for the 21st century.
Ian Van Every
Co-Founder & UK Managing Director of Lemonaid Health
Follow Ian Van Every:
About Lemonaid Health: Lemonaid Health is a telemedicine platform that uses technology to change the way people interact with health care.
Nicholas Chang
CEO & Founder of The Pill Club
Follow Nicholas Chang:
About The Pill Club: The Pill Club provides online birth control prescription and at-home delivery services.
Seth Sternberg
Co-Founder & CEO of Honor
Seth Sternberg is the Co-Founder and CEO of Honor, a non-medical home care company with a mission to enable our parents to remain in their homes as they age. Prior to Honor, Seth was the Co-Founder and CEO of Meebo, which brought instant messaging to the web and reached close to half the internet population in the United States. Meebo was acquired by Google, where Seth became a Product Director working on the Google Identity Platform, and then within GoogleX. Seth started his career with IBM’s Corporate Development group after graduating from Yale.
Follow Seth Sternberg:
About Honor, Meebo: Honor is a senior care network and technology platform that offers personalized care to improve the in-home care experience.
Roy Paxton Yih
Co-Founder and CEO of Biocare Medical
Roy Paxton Yih, BS, MA, co-founded Biocare Medical, LLC in 1997 and serves as its Chief Executive Officer and President. Roy Yih served as a Director of Sales & Marketing at Biocare Medical LLC. Roy Yih is primarily involved at sales, marketing and business development activities. He holds a BS Degree in Biochemistry from U.C. Davis and an MBA from the University of Santa Clara.
Follow Roy Paxton Yih:
About Biocare Medical: Biocare Medical is a provider of immunohistochemistry instrumentation.
Chris Mansi
CEO, Co-Founder of Viz
Dr Mansi is a former Neurosurgeon and the CEO of Viz.ai an Applied AI Healthcare company.They recently received FDA clearance for the first ever AI aided triage and notification platform, opening the door to AI in acute emergency healthcare. Chris is a clinician innovator, entrepreneur and optimist focused on increasing healthcare access, building and supporting great teams and improving provider experience. Viz.ai builds clinician facing products that enable and empower doctors, allowing them to provide the best care to patients, everytime, everywhere.
Follow Chris Mansi:
About Viz: Viz is a medical imaging company that helps optimize emergency treatment using deep learning technology.
Daniel Perez
Co-Founder, CEO of Hinge Health
With a long personal history of MSK injuries including several leg surgeries, Dan has long been passionate about improving outcomes for musculoskeletal disorders. Originally from Miami, Dan pursued a PhD in the medical sciences at the University of Oxford (currently paused), founding the Oxbridge Biotech Roundtable and OneStart, a large healthcare accelerator program. As CEO, Dan brings startup technology experience and healthcare expertise to Hinge Health.
Follow Daniel Perez:
About Hinge Health: Hinge Health is a patient-centered digital clinic for treating chronic musculoskeletal conditions.
Nichola Eliovits
Co-Founder, Chief Business Officer of DermBiont
Nick’s investment expertise spans across asset classes with an extensive focus on microbiome oriented companies across all stages of venture capital. Nick is a Managing Partner at Olive Tree Capital; he led his last company through acquisition and has successfully seeded and structured companies across multiple industries. His passion for the Microbiome originates from personal experiences with skin infections and c-diff. Nick graduated with honors from Boston University’s Questrom School of Business and started his career in commodity markets at CPM Group in New York.
Follow Nichola Eliovits:
About DermBiont, Popover: DermBiont is a biotech company that develops skin microbiome therapeutics to treat and prevent skin diseases.
John Fontein
Co-Founder of Sesame
John Fontein is Co-Founder and President at Sesame. Previously, he was the VP of Business Development at GoEuro where he oversaw all revenue functions including sales, marketing and partnerships. John began his career at Goldman Sachs where he worked in both the Investment Banking and Investment Management Divisions of the firm. John is a multi-platinum song-writer, producer, and sound designer. He is the recipient of numerous awards including an MTV Video Music Award, a Berklee Jazz Festival Award and a FringeNYC Award. John attended Saint Ann’s School in Brooklyn and graduated summa cum laude from Princeton University with a B.A. in Music and a certificate in Computer Science.
Follow John Fontein:
About Sesame: Sesame is a healthcare superstore, with over 10,000 medical practices offering affordable prices for care in-person or online.
David Goldhill
Co-Founder & CEO of Sesame
David Goldhill is the founder and CEO of Sesame.
Follow David Goldhill:
About Game Show Network, Sesame: Sesame is a healthcare superstore, with over 10,000 medical practices offering affordable prices for care in-person or online.
Jonathan M. Rothberg
Co-Founder, Product Architect & CEO of Butterfly Network
Jonathan Rothberg is Co-Founder, Product Architect & CEO at Butterfly Network.
Follow Jonathan M. Rothberg:
About Butterfly Network: Butterfly Network designs a medical imaging device that reduces the cost of real-time and three-dimensional imaging and treatment.
Nevada Sanchez
Co-Founder, ASIC Design Lead of Butterfly Network
Nevada Sanchez is a co-founder of [Butterfly Network](https://www.crunchbase.com/organization/butterfly-network#/entity). Previously, he was an FPGA developer and hardware engineer at Massachusetts Institute of Technology. Sanchez holds a bachelor’s degree in mathematics and master’s degree in engineering from Massachusetts Institute of Technology. He lives in Branford, Connecticut, United States.
Follow Nevada Sanchez:
About Butterfly Network: Butterfly Network designs a medical imaging device that reduces the cost of real-time and three-dimensional imaging and treatment.
Zhen Li
Founder, President & CEO of ADARx Pharmaceuticals
Dr. Li is a co-founder of ADARx and a successful executive with more than two decades of diverse experience in research and development in the pharmaceutical and biotech industries. Prior to ADARx, Dr. Li served as Senior VP at Arrowhead Pharmaceuticals where she led the discovery and non-clinical development of Arrowhead’s delivery platform and multiple product candidates that are now in clinical studies. Previously, Dr. Li was a director at Merck, leading a team dedicated to siRNA development. Dr. Li received her Ph.D. in Chemistry and Chemical Biology from Harvard University, and her B.S. from Peking University.
Follow Zhen Li:
About ADARx Pharmaceuticals: ADARx Pharmaceuticals is a genetic medicine company focusing on the base editing of mRNA transcripts.
Dwight Crow
Co-Founder and CEO of Whisper
Dwight Crow is a product manager at [Facebook](https://www.crunchbase.com/organization/facebook#/entity), an online social networking service. Previously, he served as the founder of Carsabi.com. He is also the Co-Founder and CEO at Whisper.ai. Crow holds a bachelor’s degree in chemical biology and computer science from the [University of California, Berkeley](https://www.crunchbase.com/organization/university-of-california-berkeley#/entity). He is based in San Francisco, California, United States.
Follow Dwight Crow:
About Meta, Whisper: Whisper develops AI-enabled, updateable hearing aids for people with hearing loss.
Andrew Song
President and Co-Founder of Whisper
Andrew Song is the President and Co-Founder at Whisper.
Follow Andrew Song:
About Whisper: Whisper develops AI-enabled, updateable hearing aids for people with hearing loss.
Shlomo Zippel
Co-Founder of Whisper
Follow Shlomo Zippel:
About Whisper: Whisper develops AI-enabled, updateable hearing aids for people with hearing loss.
Seth Harrison
Founder & Managing Partner of Apple Tree Partners
Seth Harrison is the managing partner of Apple Tree Partners and serves as Executive Chairman of Braeburn Pharmaceuticals. He has invested in life sciences since 1991. Seth has served as founding investor, acting CEO or chairman of numerous portfolio companies. He is currently also Chairman of Tokai Pharmaceuticals, Chairman of Aileron Therapeutics and Deputy Chairman of Heartware International, all companies he founded. Prior to founding ATP, Seth was a general partner at Oak Investment Partners and earlier was a venture partner at Sevin Rosen Funds. His prior investments include: ArQule, Coelacanth, Cyrano Sciences, Gloucester Pharmaceuticals, Informed Access, SGX Pharmaceuticals, Ultracision and ViroPharma. Seth received an A.B. from Princeton University, an MD and MBA both from Columbia University and completed a surgery internship at the Presbyterian Hospital in the City of New York. From 2002 – 2010 he served on the board of the International Partnership for Microbicides, a Rockefeller Foundation/Gates Foundation sponsored public-private partnership engaged in the development of anti-HIV microbicides.
Follow Seth Harrison:
About Apple Tree Partners: Apple Tree Partners is a venture capital firm that invests in pharmaceuticals, biotech, medtech, and healthcare services.
Martin Shkreli
Founder & Executive Chairman of Turing Pharmaceuticals
Martin Shkreli is the founder and CEO of Turing Pharmaceuticals. He is the founder of Retrophin, LLC (the predecessor of Retrophin, Inc.) and former President of Retrophin, Inc. since its formation. Martin Shkreli is also the founder and managing partner of MSMB Capital Management, a New York hedge fund firm founded in 2006 that manages a variety of partnerships. Prior to MSMB, Martin Shkreli was employed at Intrepid Capital Management from 2004 to 2006 and previously at Cramer Berkowitz & Co, both of which are hedge fund firms based in New York. Martin Shkreli is an experienced biotechnology and pharmaceutical industry investor, particularly in businesses with orphan drugs. Martin Shkreli received his BBA from Baruch College.
Follow Martin Shkreli:
About Shkreli Foundation, Turing Pharmaceuticals: Turing Pharmaceuticals is a biopharmaceutical company focusing on patients with unmet medical needs.
David Ronick
Co-Founder and CEO of Minded
David is a co-founder of Minded and Stash, an LP in The Fund, and mentor to entrepreneurs at TechStars, Harvard Business School and Brown University
Follow David Ronick:
About Minded: Minded is a consumer telehealth company that makes getting mental health medication easy and affordable
Mehdi Maghsoodnia
Founder and Chief Executive Officer of 1Health
Mr. Maghsoodnia is currently serving as CEO of 1Health.io and Vitagene. He is also on the board of SpineZone and MedCorder. He previously served as CEO of Rafter, BookRenter.com, SVP of products at CafePress, COO at Actiance and SVP at Intellisync. Mr. Maghsoodnia is a industry fellow at UC Berkeley where he teaches innovation and entrepreneurship. He studies EECS in UCB and Stanford with an emphasis in AI and Machine learning.
Follow Mehdi Maghsoodnia:
About 1Health: 1health’s Testing as a Service (TaaS) Solution empowers precision testing and end-to-end process management in one simple, scalable tool.
Jack Miller
Co-Founder of bttn.
Jack is currently the Co-Founder of bttn. Jack has spent time working in both enterprise technology and building international supply chains. During the pandemic, Jack coordinated the delivery of 60M units to thousands of front line workers. Through these experiences, he decided to co-found Buttonwood Inc DBA bttn. Jack is skilled at securing key partnerships and leading long term technological and logistical vision. Prior to bttn. Jack worked for NetApp as a Solutions Engineer helping implement data focused technologies at companies like McKesson, LucasFilm, Pixar, and Disney+
Follow Jack Miller:
About bttn.: bttn. offers subscription-based ordering on direct-from-manufacturer medical supplies.
JT Garwood
CEO & Co-Founder of bttn.
JT Garwood is CEO & Co-Founder of bttn. bttn. democratizes pricing on the worlds most vital supplies. JT founded bttn. to reduce the cost of healthcare. Prioritizing buyers wallets, lowering capital costs of high quality medical supplies, and price transparency through advanced data insights for healthcare providers across the country. Prior to becoming an entrepreneur, JT had a highly awarded career in sales at Microsoft. JT studied International Business and Chinese at The University of San Diego, and MBA from Whitman School of Management at Syracuse University. JT is an angel investor and early stage advisor to startups in WA & CA
Follow JT Garwood:
About bttn.: bttn. offers subscription-based ordering on direct-from-manufacturer medical supplies.
James C. Katzaroff
CEO, Chairman and Founder of Vivos Inc
A serial entrepreneur who started his first company importing minerals and pewter from Brazil while in high school in southern California, Mr. Katzaroff is constantly searching for outstanding opportunities. Hired straight out of college Mr. Katzaroff was a financial consultant for Wall Street firms Bateman Eichler, Smith Barney and EFHutton. Since 1990, he has been responsible for corporate engineering, senior-level corporate strategy, fostering investment bank relationships, and has served as a senior financial advisor for numerous start-ups and development stage companies. A strong desire to make an unshakable impact in the fight against cancer led Mr. Katzaroff to found AMI in 2006.
Follow James C. Katzaroff:
About Vivos Inc: Vivos Inc develops manufacturing equipments for the production of medical isotopes used in diagnosis and treatment of diseases.
Mark McManus, Jr
Founder and Chairman of The Healing Notes Foundation
Mark McManus, Jr. is President and Chief Executive Officer at NH Learning Solutions. A veteran of the computer training industry for more than 20 years, Mark is responsible for the company’s vision, financial performance, personnel, and organizational development. He has received a variety of awards in recognition of his numerous accomplishments. He was awarded the prestigious New Horizons President’s Cup award in 1997, the Circle of Excellence in 2000, and the New Horizons Lifetime Achievement Award in 2007. He has also received 10 North American “Franchise of the Year” awards over the past 15 years for the business performance within the Detroit, MI market. In addition, he was named one of Crain’s Detroit Business’ “40 under 40” in 1998, which recognized young, successful executives in Michigan. Mark is a member of the Young Presidents Organization Greater Detroit Chapter, as well as a member of the Franchise Advisory Committee (FAC) for New Horizons Computer Learning Centers.
Follow Mark McManus, Jr:
About Intellezy, NHLearning Solutions, The Healing Notes Foundation: The Healing Notes Foundation helps children and families cope with sickness and hospitalization by providing music therapy services.
Ray Shealy
Co-Founder of Noxsano
Follow Ray Shealy:
About Margaux Capital, Noxsano, SeatCycle: Noxsano Inc. is developing a device to treat chronic wounds.
Stevan Samuel
Co-Founder of Noxsano
Stevan has extensive experience in product development with two years in product development at P&G and five years utilizing open innovation and lean startup principles to help Fortune 500 companies build scaleable businesses.
Follow Stevan Samuel:
About Noxsano: Noxsano Inc. is developing a device to treat chronic wounds.
Jacob Adams
Co-Founder of Noxsano
Jacob has spent the past eight years as a scientist at P&G developing activated technologies providing point-of-use benefits to consumers.
Follow Jacob Adams:
About Noxsano, Procter & Gamble Company: Noxsano Inc. is developing a device to treat chronic wounds.
Wei-Wu He
Founder and CEO of Origene Technologies
Wei-Wu He is a biotech executive dedicated to the commercialization of innovative life sciences technologies for the healthcare market.He is currently Chairman and CEO of OriGene Technologies, Inc. He is also the founder and General Partner of Emerging Technology Partners, LLC (ETP), a venture firm dedicated to incubating innovative life sciences companies. He is also a Venture Partner of IDG/Accel Partners, a $4 Billion venture fund designed to fund innovative companies in China.He started his biotech career as a scientist at the inception of Human Genome Sciences, Inc.He has been involved in the funding and founding over 20 biotech companies throughout his career and has served on many biotech company boards. Most recently He was named the Executive Chairman of Casi Pharmaceuticals, a biotech company dedicated to the development of innovative cancer treatments both in China and the US.He has conducted cancer research at Mayo Clinic and at Massachusetts General Hospital as a research fellow. He has been awarded over 30 United States patents and has more than 25 original research publications.He received a Bachelor’s degree in Biochemistry from Nanjing University, P. R. China, an M.B.A. from Wharton School of the University of Pennsylvania, and a Ph.D. in Molecular Biology from Baylor College of Medicine.
Follow Wei-Wu He:
About Emerging Technology Partners, Origene Technologies: OriGene Technologies is a research tool company that provides a commercial collection of full-length human cDNAs.
William Cameron Powell
President, CMO and Co-Founder of Airstrip Technologies
An obstetrician by training, Dr. Cameron Powell stopped practicing in 2008 to focus full-time on the business of developing AirStrip, which he co-founded with Gene Powell and Trey Moore. It is that real-world medical experience that drives the continued development and expansion of the AirStrip healthcare solution suite.
Follow William Cameron Powell:
About Airstrip Technologies, San Antonio Academy, WellAware: AirStrip Technologies provides a platform that delivers critical patient information directly to a doctor’s smartphone, laptop or desktop.
Rhodemann Li
Founder, EVP Strategy & Finance of Vesselon
Mr. Li is the founder of Vesselon and is a serial medical device entrepreneur and brings more than thirty years of experience in finance, business development, strategy, patents and regulatory submissions. Prior to founding Vesselon in 2012, Mr. Li worked in private equity evaluating investment opportunities. Mr. Li co-founded an orthopedic implant company, Li Medical Technologies, which developed and sold sports medicine surgery and spinal implants. Li Medical was venture capital funded and ultimately acquired by ConMed Corporation. Mr. Li has five issued patents for medical devices. Mr. Li also worked for FMR Group, an investment vehicle for healthcare investors, and Golden Pond Healthcare, a special purpose acquisition corporation formed to assume a healthcare company, where he sourced investment opportunities. Prior to his healthcare experience, Mr. Li was a Vice President in Corporate Finance at UBS Securities and a Vice President in Corporate Lending at Manufacturers Hanover. Mr. Li holds a B.A. from Middlebury College and an M.B.A. from the University of Chicago.
Follow Rhodemann Li:
About Accelerator for Biosciences in Connect, Vesselon: Vesselon is a medical device company developing novel therapeutic Immuno-Oncology complexes.
Clay Larsen
President and CEO, Co-Founder of Vesselon
Mr. Larsen co-founded Vesselon in 2012 and brings over thirty years of executive management, marketing, sales, clinical innovation and engineering/project management in the healthcare industry. Mr. Larsen was a senior executive with FUJIFILM Medical Systems, where he was largely responsible for building the company’s first healthcare software division from the ground up. Mr. Larsen recruited the original senior architects and was instrumental in the development, marketing, commercial release and field support of Fuji’s Synapse® Picture Archive and Communication System (PACS). In a move to Silicon Valley in 1988, Mr. Larsen served in several senior roles at Acuson Corporation culminating as Vice President of New Market Development. Acuson was one of the leading ultrasound technology companies that was later acquired by Siemens. Early in his career he specialized in Sales and Marketing Management of Ultrasound and Nuclear Medicine for Picker International. Mr. Larsen holds a B.S. in Molecular Biophysics and Biochemistry from Yale University.
Follow Clay Larsen:
About Vesselon: Vesselon is a medical device company developing novel therapeutic Immuno-Oncology complexes.
Philip Fung
Founder / CEO of Kit.com
Founder/CEO @Kit.com, Engineer #15 @Facebook
Follow Philip Fung:
About Kit.com: Kit.com is a home medical exams, delivered. Kit makes health testing simpler, easier and more reliable for your patients.
Greg Burrell
Co-Founder, VP of Clinical Product & Strategy of Carbon Health
Greg is co-founder and Director of Medicine at Carbon Health. He brings to Carbon a long-standing passion for using smart technology to overhaul the health system and improve the quality of care to patients. He has been advising and leading Bay Area healthcare startups for a number of years and most recently served as Director of Content and Clinical Solutions at CareMessage, Inc. Greg received his medical degree from the University of Chicago, completed his internal medicine residency at the University of California, San Francisco and maintains a faculty appointment as Assistant Professor of Clinical Medicine at UCSF.
Follow Greg Burrell:
About Carbon Health: Carbon Health is a tech-enabled healthcare company that delivers a virtual care experience.
Drew Perkins
Co-Founder and CEO of Mojo Vision
Follow Drew Perkins:
About Mojo Vision: Mojo Vision is developing Mojo Lens, the world’s first AR smart contact lens with a built-in display that delivers Invisible Computing
Michael Wiemer
VP Eng / Co-Founder and CTO of Mojo Vision
Michael Wiemer is the Co-Founder and CTO at Mojo Vision.
Follow Michael Wiemer:
About Mojo Vision: Mojo Vision is developing Mojo Lens, the world’s first AR smart contact lens with a built-in display that delivers Invisible Computing
Alexis Borisy
Co-Founder of Blueprint Medicines
Alexis Borisy is the Chairman of the Board of Directors & Co – Founder of Foundation Medicine Inc.He is also a Partner at Third Rock Ventures.Alexis Borisy is a successful biotechnology entrepreneur with 20 years of experience building and operating innovative science-based organizations. Alexis Borisy joined the life sciences venture capital firm Third Rock Ventures in 2009 to focus on the formation, development and strategy of new companies. He co-founded Foundation Medicine and served as the company’s interim CEO through May 2011.Prior to joining Third Rock Ventures, Alexis Borisy founded CombinatoRx in 2000, serving as its Chief Executive Officer and bringing the company public on the NASDAQ. He has raised $750 million in financing and business development deals, and has authored numerous scientific papers and patents. Trained in chemistry and chemical biology at Harvard where he was a Howard Hughes Predoctoral Fellow, Alexis Borisy was honored as the Massachusetts Institute of Technology’s Technology Review Innovator of the Year. He was also chosen as the New England Entrepreneur of the Year in Life Sciences and was honored as a Presidential Scholar.Alexis Borisy’s Undergraduate Degree in Chemistry is from the University of Chicago, and he did his graduate work in the laboratory of Dr. Stuart Schreiber at Harvard University. Alexis Borisy serves on the Board of the Biotechnology Industry Organization, is an Overseer at the Boston Museum of Science, is the Chairman of Forma Therapeutics, and serves on the board of Blueprint Medicines.
Follow Alexis Borisy:
About Blueprint Medicines, Blueprint Medicines, EQRx, Third Rock Ventures: Blueprint Medicines engages in the discovery and development of highly selective kinase inhibitors for genomically defined cancer subsets.
Nick Lydon
Scientific Founder of Blueprint Medicines
Nick Lydon, Ph.D., is a scientific founder of Blueprint Medicines. Before founding his current consulting company, Granite Biopharma, LLC, Dr. Lydon served as vice president, small molecule drug discovery at Amgen. Prior to joining Amgen, he founded and led Kinetix Pharmaceuticals, Inc., a biotechnology company focused on the discovery and development of selective protein kinase inhibitors, a number of which are now advancing through clinical development. Kinetix was acquired by Amgen in 2000. Prior to Kinetix, Dr. Lydon worked at CIBA-GEIGY, in Basel, Switzerland, where he was responsible for the protein kinase inhibitor program. He and his team identified a number of protein kinase inhibitors. The most advanced drug from this program is Gleevec®, a selective Bcr-Abl inhibitor for the treatment of chronic myelogenous leukemia (CML). Dr. Lydon began his pharmaceutical career at Schering-Plough Corporation, where his research involved studies on recombinant alpha, beta and gamma interferons. In 2009, Dr. Lydon was awarded the Lasker-DeBakey Award for Clinical Medical Research for his work on developing Gleevec®, converting a fatal cancer into a manageable chronic condition. Other awards include the Warren Alpert Foundation Prize, the AACR-Bruce F. Cain Memorial Award, and the Charles F. Kettering Prize from the General Motors Cancer Research Foundation for his contributions to the discovery and development of Gleevec®. Dr. Lydon earned a B.S. in biochemistry from the University of Leeds, England, and received his Ph.D. in biochemistry from the Medical Sciences Institute, University of Dundee, Scotland. His thesis involved research work on adenylate cyclase and cAMP dependent protein kinase. Dr. Lydon served as an advisor and member of the board of directors of Ambit BioScience from 2004 to 2009 and assisted in the development of AC220, a FLT3 kinase inhibitor in Phase 2 clinical development in relapsed/refractory acute myeloid leukemia (AML).
Follow Nick Lydon:
About Blueprint Medicines: Blueprint Medicines engages in the discovery and development of highly selective kinase inhibitors for genomically defined cancer subsets.
Florent Peyre
Co-Founder & President of Small Door
Follow Florent Peyre:
About Small Door: Small Door provides veterinary services that are elevated, customer-centric, and hospitality-infused.
Josh Guttman
Co-Founder and CEO of Small Door
Prior to co-founding Small Door, Josh led a successful with diverse experiences that included management roles at a number of significant technology companies and roles in both investment banking and venture capital. From 2013 – 2017, Josh worked as a Partner on the early stage investing team at Softbank Capital, a $500 million venture capital arm of Softbank Corporation. While at Softbank, Josh led early stage investments in software businesses with a focus on healthcare and real estate. Before Softbank, Josh served as Senior Vice President at Outbrain, the leading content marketing platform, where he oversaw growth of the business from 50 to 250 worldwide employees in a three-year timespan. Previously, in 2007, Josh joined the early team at Sphere and helped grow the business to their eventual acquisition by Aol in 2008. Post-acquisition, Josh led the business as CEO for two years, ultimately initiating its divestiture and sale to Outbrain in early 2011. Josh began his career in investment banking at Robertson Stephens & Co in San Francisco where he participated on more than $400 million of private equity and debt financings from 1998 – 2002. Josh earned an AB from Duke University and an MBA from Columbia University. He lives in Brooklyn with his wife, two daughters, and boxer, Morrison.
Follow Josh Guttman:
About Small Door: Small Door provides veterinary services that are elevated, customer-centric, and hospitality-infused.
Steve Gorlin
Founder of Hycor Biomedical LLC
In January 2014, Mr. Gorlin joined the Company as its Executive Chairman. Over the past 40 years, Mr. Gorlin has founded several biotechnology and pharmaceutical companies, including Hycor Biomedical, Inc. (acquired by Agilent), Theragenics Corporation (NYSE: TGX) , CytRx Corporation (NASDAQ: CYTR), Medicis Pharmaceutical Corporation (sold to Valeant for approximately $2.6 billion), EntreMed, Inc. (NASDAQ: ENMD), MRI Interventions (MRIC) , DARA BioSciences, Inc. (NASDAQ: DARA), MiMedx (NASDAQ: MDXG), and Medivation, Inc. (NASDAQ: MDVN). Mr. Gorlin has served on the Business Advisory Council to the Johns Hopkins School of Medicine and has previously served on The Johns Hopkins BioMedical Engineering Advisory Board. He also serves on the Board of the Andrews Institute. He founded a number of non-medical related companies, including Perma-Fix, Inc., Pretty Good Privacy, Inc. sold to Network Associates, Judicial Correction Services, Inc. sold to Correctional Healthcare, and NTC China. He started The Touch Foundation, a nonprofit organization for the blind and was a principal financial contributor to the founding of Camp Kudzu for diabetic children. He presently serves as the Executive Chairman of DemeRx, Inc., and serves on the Board of NTC China, Inc.
Follow Steve Gorlin:
About Hycor Biomedical LLC: Hycor Biomedical is a medical device company that provides vitro diagnostics products.
Jeff Dachis
Founder, Chairman & CEO of One Drop
After Jeff Dachis was diagnosed with type 1 diabetes, he set out to create a data-driven digital platform that would disrupt the reactive healthcare model. In 2015, One Drop was born. The precision health company combines continuous diagnostics, predictive analytics and machine learning in an award-winning digital solution to deliver cost-saving outcomes for people worldwide living with diabetes and other chronic conditions. Next, One Drop plans to enter the market with a daily disposable, minimally invasive continuous health sensor in development designed to provide greater flexibility and insights for people living with diabetes compared to fingersticks alone. The availability of this proprietary sensor is subject to receipt of clearance or approval from the U.S. FDA. Before One Drop, Dachis co-founded Razorfish (NASDAQ: RAZF) and led its $55MM IPO, then founded the Dachis Group (acquired by Sprinklr). Dachis has appeared on Crain’s 40 Under 40 list and was named EY Entrepreneur of the Year. An internet pioneer, having helped create the first banner ad and web animation, Dachis now channels his passion for data, technology, and design at One Drop, building data-driven products that empower people to take charge of their health.
Follow Jeff Dachis:
About One Drop: One Drop is a diabetes management platform that helps people navigate diabetes together.
Cheng Liu
Founder, CEO of Eureka Therapeutics
Cheng Liu is the founder and CEO of Eureka Therapeutics, a California biotech company dedicated to antibody research and discovery for cancer immunotherapy. Prior to founding Eureka, Dr. Liu was a Principal Scientist in antibody drug discovery at Chiron (now Novartis), where he championed anti-CSF1 antibody program for treatment of bone metastasis to human clinical trials. He is the inventor of multiple issued US patents in drug discovery. In 2007, he was awarded Special US Congressional Recognition for his contributions to improving human health. Dr. Liu received his B.S. in Cell Biology and Genetics from Beijing University and a Ph.D. in Molecular Cell Biology from the University of California, Berkeley.
Follow Cheng Liu:
About Eureka Therapeutics: Eureka Therapeutics is a biotechnology company focusing on immunotherapies for the treatment of cancer.
Maria Artunduaga
Founder and CEO of Respira Labs
Follow Maria Artunduaga:
About Respira Labs: Respira Labs is building an AI-powered sensor platform to track, predict, and prevent chronic lung disease.
Ashok Subramanian
Founder/CEO of Centivo
Ashok is a successful founder and CEO with significant expertise in HR and healthcare technology businesses. He is co-founder and CEO of Liazon, the nation’s leading private benefits exchange for active employees. In 2013, Liazon was acquired by Towers Watson. Ashok continues to serve as CEO of Liazon, as well as the Head of Willis Towers Watson’s Group Exchange business. Prior to Liazon, he worked as a strategy consultant at McKinsey & Company. Ashok is often sought out for his expert commentary on private and public exchanges, their role in the new healthcare landscape and their effect on businesses. He received his undergraduate degree from Princeton University, a Masters degree from Stanford University, and an MBA from the Stanford Graduate School of Business.
Follow Ashok Subramanian:
About Centivo: Centivo offers a digital health plan aimed at self-funded employers looking to provide employees with quality care they can afford.
Alan Cohen
Chief Product Officer & Co-Founder of Centivo
Alan Cohen is the Chief Product Officer & Co-Founder at Centivo. He leads the development of Liazon’s award-winning Bright Choices® Exchange and has forged numerous partnerships with national and regional benefits providers. He knows the insurance and health care industry inside and out and is often called upon by the media for his expertise. Alan was the CEO and Co-Founder of Online Benefits, a benefits management and communication technology firm. He sold Online Benefits to A.D.A.M., and then served as President of that company. He also worked in the insurance industry for Prudential, Mass Mutual and CIGNA, and managed an insurance brokerage. Alan is a graduate of Cornell University, and earned MBAs from the Columbia Business School and the London Business School, where he won the Award for Academic Excellence.
Follow Alan Cohen:
About Centivo: Centivo offers a digital health plan aimed at self-funded employers looking to provide employees with quality care they can afford.
Sami Inkinen
CEO & Founder of Virta Health
Sami Inkinen is the Chief Executive Officer and Co-Founder of Virta Health, a specialty medical clinic that reverses type 2 diabetes safely and sustainably, without the risks, costs, or side effects of medications or surgery. Previously, Mr. Inkinen was the co-founder of the leading online real estate marketplace Trulia, serving as its COO and president and board member until its IPO and eventual sale to Zillow Group. He also worked on Microsoft’s strategy team for MS Office, and as a consultant for McKinsey & Company within the software, telecommunications, and government sectors. A physicist by training, Mr. Inkinen started his career as a radiochemist at a nuclear power plant and holds a Master of Science in engineering physics from the Helsinki University of Technology. He also earned a Master of Business Administration from Stanford University. He thinks his greatest luxury today is a small vegetable garden at his San Francisco Bay area home.
Follow Sami Inkinen:
About Virta Health: Virta delivers a clinically-proven treatment to reverse type 2 diabetes and other chronic metabolic diseases.
Oguzhan Atay
Co-Founder of BillionToOne
Oguzhan is responsible for implementing BillionToOne’s vision and for all day-to-day management decisions. During his PhD at Stanford, he has combined machine learning and genetics to solve problems in cell biology. His PhD research has been featured as Cover Article in Cell Systems, and his work has been published in high-impact peer-reviewed journals, including Cell and Journal of Cell Biology.
Follow Oguzhan Atay:
About BillionToOne: BillionToOne is a precision diagnostics company that makes molecular diagnostics accurate, efficient, and accessible for all.
Johannes Fruehauf
Founder, President & Executive Director of LabCentral
Johannes Fruehauf is the Founder & CEO LabCentral/Biolabs.He is responsible for all aspects of LabCentral’s operation. Johannes is a physician and successful biotech entrepreneur. Prior to LabCentral, he founded Cambridge Biolabs, a contract research facility serving startup and virtual companies in Kendall Square. He is also a co-founder of ViThera Pharmaceuticals, Deltix and Cequent Pharmaceuticals, and an advisor or board member to numerous life sciences companies and non-profits. Johannes earned his medical degree at the University of Frankfurt and his PhD at the University of Heidelberg (Germany).
Follow Johannes Fruehauf:
About Arkuda Therapeutics, BioLabs, Cequent Pharmaceuticals, Deltix, LabCentral, Mission BioCapital: LabCentral developing novel cancer treatments: Conkwest, Inc, headquartered in DelMar, California, is opening its research laboratory at
Marc Korczykowski
CEO and Co-Founder of Hura Imaging
Marc Korczykowski is Hura Imaging’s Co-Founder and CEO.
Follow Marc Korczykowski:
About Hura Imaging: Hura Imaging develops and commercializes novel CT technology that decreases radiation dose significantly in patient management.
Danny JJ Wang
CSO and Co-Founder of Hura Imaging
Danny JJ Wang is the Co-Founder and Chief Science Officer of Hura Imaging.
Follow Danny JJ Wang:
About Hura Imaging: Hura Imaging develops and commercializes novel CT technology that decreases radiation dose significantly in patient management.
Harry Ritter
Founder and CEO of Alma
Harry Ritter is the Founder of Alma Health.
Follow Harry Ritter:
About Alma: Alma is a membership-based network for mental health care providers.
Erica Chidi
Co-Founder & CEO of LOOM
Erica Chidi is a Co-Founder and Chief Executive Officer at LOOM.
Follow Erica Chidi:
About LOOM: LOOM is a platform helping women optimize their sexual and reproductive wellbeing.
Andrew Grover
Co-Founder and Chief Development Officer of Tend
Andy Grover is Head of Development at Tend, the dental brand bringing a hospitality mindset to oral health. With vast experience in real estate, healthcare and branding, Andy has established himself as a leader in building spaces tailored specifically to guests’ needs and emotions. At Tend, Andy spearheads every aspect of development, focusing on finding the right locations to create a holistic environment that supports guests, marrying hospitality and the sensibility of the healthcare industry. Prior to Tend, Andy was the VP of Real Estate and Development at One Medical Group. In this role, he worked with clinicians and technology specialists to develop the practice’s signature design, helping scale the industry-leading healthcare model into the business it is today.
Follow Andrew Grover:
About Tend: Tend is a technology-driven dental startup that provides hassle-free, personalized, and straightforward dental services.
Doug Hudson
CEO and Co-Founder of Tend
Doug Hudson is the founder and Chief Executive Officer of Tend. Born out of the need for systemic change across the dental industry, Doug’s vision is for Tend to set a new standard for oral health, starting at the dentist. As CEO, Doug applies his past experience spearheading numerous high-growth healthcare ventures to bring a hospitality mindset to the dental industry. Previously, Doug was the founding CEO of SmileDirectClub, a leading direct-to-consumer orthodontics company. Prior to this, he founded and led several consumer health companies including DiabetesCareClub and CPAPCareClub, Inc. and HearingPlanet, Inc., the latter of which became the largest online hearing aid distributor in the U.S. during his tenure.
Follow Doug Hudson:
About Tend: Tend is a technology-driven dental startup that provides hassle-free, personalized, and straightforward dental services.
Michael Stenclik
Co-Founder of Tend
Michael Stenclik is co-Founder and Chief of Staff at Tend, the dental brand bringing a hospitality mindset to oral health. Michael’s eye for innovation and expertise in bridging gaps within disjointed systems played a key role in the early stages of Tend’s development. In his current role as Chief of Staff, Michael oversees operations across finance, regulation, talent and product, in addition to driving various strategic projects internally. Previously, Michael held a product management role at Quartet Health, a behavioral health technology company. In this role Michael helped develop an innovative product that delivered improved outcomes while lowering the total cost of care, creating a better experience for both guest and provider. Prior to this, Michael served as an engagement manager for Farenheit 212, consulting for several Fortune 500 companies.
Follow Michael Stenclik:
About Tend: Tend is a technology-driven dental startup that provides hassle-free, personalized, and straightforward dental services.
Samir Housri
CEO & Co-Founder of The Mednet
Samir Housri the CEO & Co-founder of theMednet. Under his leadership theMednet has become the largest online physician network in Oncology and one of the fastest growing in medicine. Samir’s career spans nearly 20 years in digital media that spans operations, technology and strategy. Most recently he was part of the investment team at Rho Ventures where he sat on multiple boards and deployed over $50M in capital. Prior to that, he was part of EMI Music’s global business development team where he drove the launch of EMI’s ad-supported video platform. He was also involved in all aspects of digital content licensing and distribution, including contract negotiations, technical implementation and monetization. Prior to EMI, Samir served as a management consultant with Bain & Company where he worked on strategy for technology and media clients. He started his career as a software engineer for Major League Baseball and was a key member of the team that built MLB.com.
Follow Samir Housri:
About The Mednet: The Mednet is a physician-only community for expert answers to real world clinical questions in oncology.
Nadine Housri
Co Founder & Chief Medical Officer of The Mednet
Follow Nadine Housri:
About The Mednet, Yale University School of Medicine: The Mednet is a physician-only community for expert answers to real world clinical questions in oncology.
Flaviu Simihaian
Co-Founder & CEO of Troy Medicare
Flaviu Simihaian is the co-founder and CEO of Troy Medicare, the first pharmacy-powered, AI-driven Medicare Advantage plan. Flaviu also co-founded and is the chairman of Amplicare (previously iMedicare), a web-based SaaS platform that 7,000 pharmacies use to manage and grow their business.
Follow Flaviu Simihaian:
About TechAngels, Troy Medicare: Troy Medicare is arming independent pharmacies with a health plan and platform tailored to their most vulnerable patients.
Stephen Chen
Founder & CEO of Scanwell Health
Co-Founder and President at Learn To Be Foundation. Founder at Petnostics.
Follow Stephen Chen:
About Learn To Be Foundation, Petnostics, Scanwell Health: Scanwell Health is an FDA-cleared urine testing application.
Fabien Beckers
Founder & CEO of Arterys
Fabien Beckers is the CEO and co-founder of Arterys, a cloud/deep learning startup that is disrupting the medical imaging space and building image-based precision medicine tools. Fabien has led the growth of the company from four co-founders to a team of 34 today. Under his leadership, the company has become a pioneer in cloud-based medical imaging software, offering the first FDA-cleared end-to-end cloud infrastructure for medical imaging. They key advantages of the platform being automatic aggregation of real-world data and ability to scale and distribute the processing of increasingly large, complex datasets. Fabien’s vision for the company is to accelerate data-driven medicine by building precision medicine tools based on the consistent quantification of medical image features in combination with molecular, genomics and patient history data. Fabien holds a PhD in Quantum Physics from the University of Cambridge and a masters of business from Stanford University.
Follow Fabien Beckers:
About Arterys: Arterys is a medical imaging platform to deliver clinical AI products over the internet.
Clinton Phillips
Founder of 2nd.MD and Medici & CEO of Medici
Clinton Phillips is the founder and CEO of Medici and launched the company in early 2017 with a vision to create technology that would revolutionize the way doctors provide care to their patients and to build a next generation virtual health+care system that gives patients access to a personal medical team made up of exceptional doctors, nurses, and specialists right from their phone.
As a serial-entrepreneur Clinton previously founded 2nd.MD in response to frustrations he had experienced when seeking medical care for his daughter, Gabi, who had suffered a stroke shortly after birth. 2nd.MD has since helped thousands of people in over 45 countries gain access to high-quality second opinions with outcomes that has saved lives and lowered healthcare and recovery costs for patients, providers and carriers. Clint sold 2nd.MD to Accolade in 2021.
Before this, Clinton served as a consultant to The Vitality Group working to lower healthcare spending through employee education and engagement programs. Clinton is also a certified Chiropractor and founded the successful Colorado-based Aspen Back & Body, a non-surgical rehabilitation clinic for people with back problems. Originally from South Africa, Clinton and his family now reside in Austin, Texas.
Follow Clinton Phillips:
About 2nd.MD, Medici: Medici is a mobile technology platform that provides text, video, and voice chats between patients and doctors.
